Alnylam Pharmaceuticals Inc (ALNY)
144.39
-0.62
(-0.43%)
USD |
NASDAQ |
Apr 19, 16:00
144.39
0.00 (0.00%)
After-Hours: 16:52
Alnylam Pharmaceuticals Cash from Operations (TTM): 104.16M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 104.16M |
| September 30, 2023 | 1.973M |
| June 30, 2023 | -472.72M |
| March 31, 2023 | -536.56M |
| December 31, 2022 | -541.27M |
| September 30, 2022 | -559.44M |
| June 30, 2022 | -578.19M |
| March 31, 2022 | -577.23M |
| December 31, 2021 | -641.69M |
| September 30, 2021 | -614.70M |
| June 30, 2021 | -590.99M |
| March 31, 2021 | -604.46M |
| December 31, 2020 | -614.96M |
| September 30, 2020 | -687.80M |
| June 30, 2020 | -760.10M |
| March 31, 2020 | -336.08M |
| December 31, 2019 | -278.43M |
| September 30, 2019 | -232.90M |
| June 30, 2019 | -204.08M |
| March 31, 2019 | -595.46M |
| December 31, 2018 | -562.62M |
| September 30, 2018 | -515.20M |
| June 30, 2018 | -459.76M |
| March 31, 2018 | -438.12M |
| December 31, 2017 | -382.79M |
| Date | Value |
|---|---|
| September 30, 2017 | -358.08M |
| June 30, 2017 | -335.25M |
| March 31, 2017 | -324.41M |
| December 31, 2016 | -307.70M |
| September 30, 2016 | -282.43M |
| June 30, 2016 | -261.26M |
| March 31, 2016 | -246.51M |
| December 31, 2015 | -189.14M |
| September 30, 2015 | -172.71M |
| June 30, 2015 | -159.05M |
| March 31, 2015 | -150.22M |
| December 31, 2014 | -165.64M |
| September 30, 2014 | -151.38M |
| June 30, 2014 | -132.38M |
| March 31, 2014 | -109.36M |
| December 31, 2013 | -68.66M |
| September 30, 2013 | -115.20M |
| June 30, 2013 | -88.27M |
| March 31, 2013 | -86.36M |
| December 31, 2012 | -115.61M |
| September 30, 2012 | -71.86M |
| June 30, 2012 | -106.09M |
| March 31, 2012 | -110.98M |
| December 31, 2011 | -87.07M |
| September 30, 2011 | -82.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-760.10M
Minimum
Jun 2020
104.16M
Maximum
Dec 2023
-459.23M
Average
-559.44M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Ionis Pharmaceuticals Inc | -307.51M |
| Pfizer Inc | 8.70B |
| Blueprint Medicines Corp | -436.85M |
| Madrigal Pharmaceuticals Inc | -324.23M |
| Sarepta Therapeutics Inc | -500.99M |